Viewing nowCombinationWidian Duo Tablet 12.5/850 Milligrams
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202302749 · Approved 2023.09.13 · Insurance code 660703970
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with type 2 diabetes, in conjunction with diet and exercise. It is particularly administered to patients whose blood sugar is inadequately controlled, and caution is required when using this medication in patients with concomitant cardiovascular disease. Therefore, consulting with a healthcare professional for appropriate management and use is advised for better blood sugar control.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this drug from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this drug is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This drug should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see item 1) under section 3. Patients Requiring Caution in Administration in Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this drug should be discontinued immediately (see item 2) under section 2. Patients in Whom the Drug Must Not Be Administered in Precautions for Use). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but severe condition known as lactic acidosis, and immediate medical attention is required if symptoms occur. Additionally, caution should be exercised as hypoglycemia may occur when used in combination with insulin or sulfonylureas. Patients with allergies to any ingredients in this medication or those with severely impaired kidney function, acute infections, or dehydration should not take this medication. Patients should temporarily stop taking this medication before and after tests using radiographic contrast agents and should resume after confirming normal kidney function. Pregnant or breastfeeding women are advised not to use this medication. Patients with compromised kidney function, elderly patients, or those at risk of fluid loss should have their kidney function and fluid status monitored regularly before and during treatment with this medication. This medication may cause side effects such as gastrointestinal disturbances, urinary tract infections, genital infections, increased urination, hypoglycemia, etc., so patients should consult their healthcare provider if any unusual symptoms arise. Alcohol consumption may increase the risk of lactic acidosis, hence drinking should be avoided during treatment. Especially, patients with cardiovascular issues such as heart failure, acute myocardial infarction, or shock should be cautious when using this medication. Regular blood tests to monitor liver function, kidney function, and vitamin B12 levels are recommended during treatment. If surgery is planned, this medication should be stopped 48 hours prior to the surgery and resumed after confirming normal kidney function post-surgery. This medication is not recommended for children under the age of 18, and special attention is required for elderly patients aged 75 and over due to the increased risk of fluid loss. In case of overdose, serious side effects such as lactic acidosis may occur, hence prescribed dosages should always be adhered to, and immediate emergency treatment should be sought if unusual symptoms arise.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be kept in a tightly sealed container. It is best to store it at room temperature between 1 degree Celsius and 30 degrees Celsius. This will help maintain the medication's efficacy safely over time.
White, bilaterally convex, oval-shaped film-coated tablet with a pink tint
30 tablets/bottle, 60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.